High urinary homoarginine excretion is associated with low rates of all-cause mortality and graft failure in renal transplant recipients

Amino Acids

Volumn 47, Issue 9, 2015, Pages 1827-1836

  Frenay, Anne Roos S ^a   Kayacelebi, Arslan Arinc ^b   Beckmann, Bibiana ^b   Soedamah Muhtu, Sabita S ^c   De Borst, Martin H ^a   Van Den Berg, Else ^a   Van Goor, Harry ^a   Bakker, Stephan J L ^a   Tsikas, Dimitrios ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Cardiovascular risk; Graft survival; Kidney; Transplantation

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; ANTIVITAMIN K; CALCINEURIN INHIBITOR; CALCIUM; HOMOARGININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHOSPHATE; PREDNISONE; RAPAMYCIN; UREA; URIC ACID; VITAMIN D;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ALBUMINURIA; AMINO ACID URINE LEVEL; ARTICLE; BODY SURFACE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEATH; DIASTOLIC BLOOD PRESSURE; DRUG USE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME; URIC ACID URINE LEVEL; BIOLOGICAL MODEL; DISEASE FREE SURVIVAL; DONOR; FOLLOW UP; GRAFT REJECTION; SURVIVAL RATE; URINE;

ADULT; AGE FACTORS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HOMOARGININE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MODELS, BIOLOGICAL; SIROLIMUS; SURVIVAL RATE; TISSUE DONORS;

EID: 84940459703     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-015-2038-6     Document Type: Article

References (44)

1. Atzler D, Rosenberg M, Anderssohn M et al (2013) Homoarginine - an independent marker of mortality in heart failure. Int J Cardiol 168:4907-4909
2. Atzler D, Gore MO, Ayers CR et al (2014) Homoarginine and cardiovascular outcome in the population-based Dallas Heart Study. Arterioscler Thromb Vasc Biol 34:2501-2507
3. Bretscher LE, Li H, Poulos TL, Griffith OW (2003) Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)- and N5-(iminoalkenyl)-ornithines. J Biol Chem 278:46789-46797
4. Drechsler C, Meinitzer A, Pilz S et al (2011) Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients. Eur J Heart Fail 13:852-859
5. Drechsler C, Kollerits B, Meinitzer A et al (2013) Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study. PLoS One 8:e63560
6. Frenay AR, van den Berg E, de Borst MH, Beckmann B, Tsikas D, Feelisch M, Navis G, Bakker SJ, van Goor H (2015) Plasma ADMA associates with all-cause mortality in renal transplant recipients. Amino Acids. doi: 10.1007/s00726-015-2023-0
7. Hecker M, Walsh DT, Vane JR (1991) On the substrate specificity of nitric oxide synthase. FEBS Lett 294:221-224
8. Israni AK, Leduc R, Jacobson PA et al (2013) Inflammation in the setting of chronic allograft dysfunction post-kidney transplant: phenotype and genotype. Clin Transplant 27:348-358
9. Jones SP, Bolli R (2006) The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40:16-23
10. Kasiske BL (2000) Cardiovascular disease after renal transplantation. Semin Nephrol 20:176-187
11. Kayacelebi AA, Nguyen TH, Neil C et al (2014a) Homoarginine and 3-nitrotyrosine in patients with takotsubo cardiomyopathy. Int J Cardiol 173:546-547
12. Kayacelebi AA, Beckmann B, Gutzki FM, Jordan J, Tsikas D (2014b) GC-MS and GC-MS/MS measurement of the cardiovascular risk factor homoarginine in biological samples. Amino Acids 46:2205-2217
13. Khalil AA, Tsikas D, Akolekar R et al (2013) Asymmetric dimethylarginine, arginine and homoarginine at 11-13 weeks' gestation and preeclampsia: a case-control study. J Hum Hypertens 27:38-43
14. Kopple JD, Greene T, Chumlea WC et al (2000) Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int 57:1688-1703
15. Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604-612
16. Mallon DH, Summers DM, Bradley JA, Pettigrew GJ (2013) Defining delayed graft function after renal transplantation: simplest is best. Transplantation 96:885-889
17. Marescau B, Nagels G, Possemiers I, De Broe ME, Becaus I, Billiouw JM, Lornoy W, De Deyn PP (1997) Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency. Metabolism 46:1024-1031
18. März W, Meinitzer A, Drechsler C et al (2010) Homoarginine, cardiovascular risk, and mortality. Circulation 122:967-975
19. Moali C, Boucher JL, Sari MA et al (1998) Substrate specificity of NO synthases: detailed comparison of l-arginine, homo-l-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-l-arginine. Biochemistry 37:10453-10460
20. Molnar MZ, Kovesdy CP, Bunnapradist S et al (2011) Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant 11:1006-1015
21. Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012
22. O'Connor PM, Cowley AW Jr (2010) Modulation of pressure-natriuresis by renal medullary reactive oxygen species and nitric oxide. Curr Hypertens Rep 12:86-92
23. Ojo AO, Hanson JA, Wolfe RA et al (2000) Long-term survival in renal transplant recipients with graft function. Kidney Int 57:307-313
24. Passauer J, Pistrosch F, Bussemaker E (2005) Nitric oxide in chronic renal failure. Kidney Int 67:1665-1667
25. Pilz S, Meinitzer A, Tomaschitz A et al (2011a) Low homoarginine concentration is a novel risk factor for heart disease. Heart 97:1222-1227
26. Pilz S, Tomaschitz A, Meinitzer A et al (2011b) Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography. Stroke 42:1132-1134
27. Pilz S, Edelmann F, Meinitzer A et al (2014) Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction. J Card Fail 20:923-930
28. Ravani P, Maas R, Malberti F et al (2013) Homoarginine and mortality in pre-dialysis chronic kidney disease (CKD) patients. PLoS One 8:e72694
29. Rettkowski O, Wienke A, Hamza A et al (2007) Low body mass index in kidney transplant recipients: risk or advantage for long-term graft function? Transplant Proc 39:1416-1420
30. Smith GL, Lichtman JH, Bracken MB, Shlipak Phillips CO, DiCapua P et al (2006) Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47:1987-1996
31. Takahashi T, Harris RC (2014) Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice. J Diabetes Res 2014:590541
32. The Hague (2006) Dutch food composition table (NEVO 2006) NEVO table 2006 (dutch nutrient databank: NEVO table 2006)
33. Tomaschitz A, Meinitzer A, Pilz S et al (2014) Homoarginine, kidney function and cardiovascular mortality risk. Nephrol Dial Transplant 29:663-671
34. Tomaschitz A, Verheyen N, Gaksch M, Meinitzer A, Pieske B, Kraigher-Krainer E, Colantonio C, März W, Schmidt A, Belyavskiy E, Rus-Machan J, van Ballegooijen AJ, Stiegler C, Amrein K, Ritz E, Fahrleitner-Pammer A, Pilz S (2015) Homoarginine in patients with primary hyperparathyroidism. Am J Med Sci 349:306-311
35. Valtonen P, Laitinen T, Lyyra-Laitinen T et al (2008) Serum l-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ J 72:1879-1884
36. van den Berg E, Engberink MF, Brink EJ et al (2012a) Dietary acid load and metabolic acidosis in renal transplant recipients. Clin J Am Soc Nephrol 7:1811-1818
37. van den Berg E, Geleijnse JM, Brink EJ et al (2012b) Sodium intake and blood pressure in renal transplant recipients. Nephrol Dial Transplant 27:3352-3359
38. van den Berg E, Engberink MF, Brink EJ et al (2013) Dietary protein, blood pressure and renal function in renal transplant recipients. Br J Nutr 109:1463-1470
39. van den Berg E, Pasch A, Westendorp WH et al (2014) Urinary sulfur metabolites associate with a favorable cardiovascular risk profile and survival benefit in renal transplant recipients. J Am Soc Nephrol 25:1303-1312
40. Wu G, Bazer FW, Davis TA et al (2009) Arginine metabolism and nutrition in growth, health and disease. Amino Acids 37:153-168
41. Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80:1107-1213
42. Xia Z, Vanhoutte PM (2011) Nitric oxide and protection against cardiac ischemia. Curr Pharm Des 17:1774-1782
43. Yang Z, Ming XF (2006) Endothelial arginase: a new target in atherosclerosis. Curr Hypertens Rep 8:54-59
44. Zoccali C (2006) Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int 70:26-33